603079.SH
圣达生物
SSE · Healthcare · Drug Manufacturers - Specialty & Generic · CN
CNY 12.63
−9.98%Margins
Gross margin
25.8%
EBITDA margin
19.5%
EBIT margin
8.6%
Net margin
6.5%
FCF margin
1.7%
3.4%
Return on equity
2.4%
Return on assets
3.7%
Return on invested capital
0.38x
Asset turnover
CNY 156.8M
Cash from operations
—
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Mar 1, 2026